Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a clonal disorder caused by a malignant transformation of a hematopoietic stem cell. Mature granulocytes and precursors proliferate and increase in bone marrow and peripheral blood.
The annual incidence is 1–2 cases every 100,000 inhabitants/year and increases with age, with a male prevalence. It account for 15–20 % of all cases of leukemia in adult Western population. The disease is characterized by a reciprocal translocation t(9;22) (q34;q11) called Philadelphia chromosome (Ph). The Ph chromosome is present in more than 90 % of adult CML patients, in 15–30 % of adult acute lymphoblastic leukemia (ALL), and in 2 % of acute myeloid leukemia (AML). Diagnosis is often based on morphological analysis of peripheral blood that showed increased mature myeloid cells, eosinophils, and basophils. Characterization of disease is...
KeywordsChronic Myeloid Leukemia Hematopoietic Stem Cell Transplantation Chronic Myeloid Leukemia Patient Cytogenetic Response Major Molecular Response
- Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27:6041–6051CrossRefPubMedGoogle Scholar